A Study to Assess the Safety and Efficacy Of Tafamidis In Chinese Participants With Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

NCT04814186 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
53
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer